HBM PARTNERS
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through all stages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
HBM PARTNERS
Social Links:
Industry:
Biotechnology Financial Services Life Science Venture Capital
Founded:
2001-01-01
Status:
Active
Contact:
+41 43 888 7171
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Nginx Microsoft Exchange Online
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
DDF Ventures
DDF Ventures manages and finances the development of early-stage life-sciences companies.
Latitude
Latitude is the sister fund to London-based seed investor LocalGlobe, supporting founders from series B onwards.
VentureFriends
VentureFriends is a venture capital fund that invests in tech-enabled companies.
Zeev Ventures
Zeev Ventures is an early-stage venture fund that invests in technology, financial, e-commerce, and consumer service sectors.
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-06-14 | Dren Bio | HBM Partners investment in Series B - Dren Bio | 65 M USD |
2022-06-08 | Mineralys Therapeutics | HBM Partners investment in Series B - Mineralys Therapeutics | 118 M USD |
2022-05-13 | Odyssey Therapeutics | HBM Partners investment in Series B - Odyssey Therapeutics | N/A |
2022-05-02 | Vascular Dynamics | HBM Partners investment in Series D - Vascular Dynamics | N/A |
2022-04-25 | Farmalisto | HBM Partners investment in Series B - Farmalisto | N/A |
2022-04-22 | Sphingotec GmbH | HBM Partners investment in Convertible Note - Sphingotec GmbH | N/A |
2022-03-30 | Neuron23 | HBM Partners investment in Series C - Neuron23 | 100 M USD |
2022-03-28 | Aculys Pharma | HBM Partners investment in Series B - Aculys Pharma | 2.8 B JPY |
2022-03-07 | Karius | HBM Partners investment in Series B - Karius | N/A |
2022-01-18 | Mineralys Therapeutics | HBM Partners investment in Series A - Mineralys Therapeutics | N/A |